These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18708395)

  • 21. Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses' Health Study.
    Brantley KD; Ziegler RG; Craft NE; Hankinson SE; Eliassen AH
    Cancer Epidemiol Biomarkers Prev; 2024 Aug; ():. PubMed ID: 39190182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women.
    Lim VW; Li J; Gong Y; Jin A; Yuan JM; Yong EL; Koh WP
    Endocr Relat Cancer; 2014 Apr; 21(2):263-73. PubMed ID: 24322303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
    Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
    Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.
    Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A
    Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
    Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
    Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
    Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
    Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative weight at age 12 and risk of postmenopausal breast cancer.
    Bardia A; Vachon CM; Olson JE; Vierkant RA; Wang AH; Hartmann LC; Sellers TA; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):374-8. PubMed ID: 18250344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer.
    Modugno F; Kip KE; Cochrane B; Kuller L; Klug TL; Rohan TE; Chlebowski RT; Lasser N; Stefanick ML
    Int J Cancer; 2006 Mar; 118(5):1292-301. PubMed ID: 16161054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between cutaneous nevi and breast cancer in the Nurses' Health Study: a prospective cohort study.
    Zhang M; Zhang X; Qureshi AA; Eliassen AH; Hankinson SE; Han J
    PLoS Med; 2014 Jun; 11(6):e1001659. PubMed ID: 24915186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogens and Their Genotoxic Metabolites Are Increased in Obese Prepubertal Girls.
    Mauras N; Santen RJ; Colón-Otero G; Hossain J; Wang Q; Mesaros C; Blair IA
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2322-8. PubMed ID: 25856214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study.
    Falk RT; Brinton LA; Dorgan JF; Fuhrman BJ; Veenstra TD; Xu X; Gierach GL
    Breast Cancer Res; 2013 Apr; 15(2):R34. PubMed ID: 23607871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT.
    Dallal CM; Tice JA; Buist DS; Bauer DC; Lacey JV; Cauley JA; Hue TF; Lacroix A; Falk RT; Pfeiffer RM; Fuhrman BJ; Veenstra TD; Xu X; Brinton LA;
    Carcinogenesis; 2014 Feb; 35(2):346-55. PubMed ID: 24213602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
    Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
    Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.
    Moore SC; Matthews CE; Ou Shu X; Yu K; Gail MH; Xu X; Ji BT; Chow WH; Cai Q; Li H; Yang G; Ruggieri D; Boyd-Morin J; Rothman N; Hoover RN; Gao YT; Zheng W; Ziegler RG
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27193440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.